查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908261

计算病理学市场规模、份额和趋势分析报告：按组件、应用、技术、最终用途、地区和细分市场预测（2026-2033 年）

Computational Pathology Market Size, Share & Trends Analysis Report By Component, By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

计算病理学市场概览

2025年全球计算病理学市场规模估计为7.2868亿美元，预计到2033年将达到14.4762亿美元。

预计从 2026 年到 2033 年，该行业将以 9.21% 的复合年增长率成长。这一增长归因于医疗保健领域的投资不断增加，这得益于机器学习和人工智慧 (AI) 技术的日益融合、对快速诊断先进解决方案的需求不断增长、慢性病患病率不断上升，以及专注于开发先进解决方案的市场参与企业。

癌症等慢性疾病的日益普及是推动市场发展的主要因素。癌症的高发生率要求病理学家掌握病理数据，以便为每位患者制定个人化治疗方法。这导致病理学家越来越倾向于采用数位病理学，因为数位病理学可以提高诊断速度和准确性，并提供治疗建议，从而改善患者预后。例如，根据2023年8月发表在《病理学杂誌》（Journal of Pathology）上的一项研究，用于分析和解读组织病理学影像的深度学习和人工智慧（AI）演算法有望显着提高诊断准确性和效率，尤其是在癌症诊断和预后方面。

将机器学习和人工智慧技术融入病理工作流程将显着改变诊断过程。例如，Proscia 于 2024 年 10 月发布了一款数位病理工具包，旨在支援人工智慧模型的开发。这些工具使生命科学研究人员能够将切片检查切片影像转化为定量数据，用于训练底层模型、促进生物标记的发现并改善诊断。此类解决方案的开发能够实现影像的快速准确分析，使病理学家能够识别可能预示疾病进展的模式。透过自动化常规任务，人工智慧使病理学家能够专注于更复杂的诊断挑战，从而提高效率和准确性。这项变革将提升诊断准确性，并透过预测建模推动个人化医疗的发展。

市场蕴藏着巨大的机会，而这主要得益于以下关键因素：人工智慧 (AI)、机器学习 (ML) 和数位影像技术的进步正在变革病理学工作流程，使组织切片的分析更加快速精准，并为疾病的诊断和预后提供关键资讯。随着癌症和心血管疾病等慢性疾病在全球范围内的日益流行，人们对快速准确诊断的需求也与日俱增，而这项技术进步正满足了这一需求。

此外，远距病理学的日益普及正在改善医疗服务的可近性，使偏远地区的专家能够获得咨询，尤其是在医疗资源有限的地区。数位医疗系统的整合提高了检查室效率，实现了日常工作的自动化，使病理学家能够专注于复杂的诊断，从而提高了诊断的准确性，并促进了个人化医疗的发展。此外，医疗服务提供者和产业相关人员对人工智慧驱动的病理诊断解决方案的研发投入不断增加，也刺激了创新和市场成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章 计算病理学市场变数、趋势和范围

  • 市场动态
  • 使用案例研究结果
  • 计算病理学市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析
    • 科技趋势分析

第四章 计算病理学市场：按组件分類的估算和趋势分析

  • 按组件分類的市场份额（2025 年和 2033 年）
  • 全球计算病理学市场：组成部分展望
  • 软体
  • 服务

第五章 计算病理学市场：按应用、估算和趋势分析

  • 按应用领域分類的市场份额（2025 年和 2033 年）
  • 全球计算病理学市场：按应用领域分類的展望
  • 疾病诊断
  • 药物发现与开发
  • 学术研究

第六章 计算病理学市场：依技术分類的估算与趋势分析

  • 按技术分類的市场份额（2025 年和 2033 年）
  • 全球计算病理学市场：技术展望
  • 机器学习（ML）
    • 深度学习
    • 和老师
    • 无人监管
    • 其他的
  • 自然语言处理（NLP）模型
  • 电脑视觉
  • 其他的

第七章 计算病理学市场：依最终用途分類的估算与趋势分析

  • 按最终用途分類的市场份额（2025 年和 2033 年）
  • 全球计算病理学市场：终端用户展望
  • 医院和诊断实验室
  • 生物技术和製药公司
  • 学术和研究机构
  • 其他的

第八章 计算病理学市场按地区、估算和趋势分析、组成部分、应用、技术和最终用途划分

  • 区域市场占有率分析（2025 年和 2033 年）
  • 区域市场概览
  • 全球市场概览（按地区划分）
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 主要企业市占率和地位分析（2025 年）
  • 公司简介
    • 徕卡生物系统努斯洛赫有限公司（丹纳赫子公司）
    • Hamamatsu Photonics KK
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Aiforia/Aiforia Technologies PLC
    • Epredia（3DHISTECH Ltd.）
    • Visiopharm A/S
    • Proscia Inc.
    • Mindpeak GmbH
    • Akoya Biosciences, Inc.（Quanterix 的子公司）
    • Paige AI, Inc.
    • CellaVision
    • aetherAI
    • Qritive
    • IBEX（IBEX MEDICAL ANALYTICS）
    • Nucleai, Inc.
Product Code: GVR-4-68040-548-5

Computational Pathology Market Summary

The global computational pathology market size was estimated at USD 728.68 million in 2025 and is projected to reach USD 1,447.62 million by 2033, growing at a CAGR of 9.21% from 2026 to 2033. The growth is attributed to the rising integration of machine learning and artificial intelligence (AI) technologies, the increasing demand for advanced solutions for faster diagnosis, the rising prevalence of chronic diseases, and increasing investment in healthcare, supported by market players focused on developing advanced solutions.

The growing prevalence of chronic diseases, such as cancer, predominantly drives the market. Owing to the high prevalence of cancer, pathologists require pathology data that can facilitate customizing therapies for patients. Thereby, digital pathology is increasingly being preferred by pathologists, as it accelerates the rate of diagnosis, increases diagnostic accuracy, and provides therapeutic recommendations to improve patient outcomes. For instance, according to a study published in the Journal of Pathology in August 2023, deep learning and artificial intelligence (AI) algorithms to analyze and interpret histopathology images promise substantial improvements in diagnostic accuracy and efficiency, especially for cancer diagnosis and prognosis.

The incorporation of machine learning and AI technologies into pathology workflows significantly transforms the diagnostic process. For instance, in October 2024, Proscia introduced digital pathology toolkits designed to facilitate the development of AI models. These tools enable life science researchers to convert biopsy slide images into quantitative data for training foundation models, improving biomarker discovery, and diagnostics. The development of such solutions enables the rapid and accurate analysis of images, allowing pathologists to identify patterns that may indicate disease progression. By automating routine tasks, AI enables pathologists to focus on more complex diagnostic challenges, thereby improving efficiency and accuracy. This shift enhances diagnostic precision and supports the development of personalized medicine through predictive modeling.

The market holds substantial opportunities driven by significant factors. Advances in artificial intelligence (AI), machine learning (ML), and digital imaging are transforming pathological workflows, enabling faster, more precise analysis of tissue slides and providing critical insights into disease diagnosis and prognosis. This technological progress is addressing the growing demand for rapid, accurate diagnostics, owing to the rising global prevalence of chronic diseases such as cancer and cardiovascular conditions.

Moreover, increasing adoption of telepathology is expanding remote expert consultations and improving healthcare access, especially in underserved regions. Integrating digital health systems enhances laboratory efficiency, automates routine tasks, and allows pathologists to focus on complex diagnostics, fostering greater accuracy and personalized medicine development. Furthermore, rising investments by healthcare providers and industry players in developing AI-powered pathology solutions stimulate innovation and market growth.

Global Computational Pathology Market Report Segmentation

This report forecasts revenue growth and provides, at global, regional, and country levels, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global computational pathology market report based on components, application, technology, end-use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Diagnosis
  • Drug Discovery & Development
  • Academic Research
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning (ML)
    • Deep Learning
    • Supervised
    • Unsupervised
    • Others
  • Natural Language Processing (NLP) Models
  • Computer Vision
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional scope
    • 1.1.2. Component
    • 1.1.3. Technology
    • 1.1.4. Application
    • 1.1.5. End Use
  • 1.2. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database.
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component
    • 2.2.2. Technology
    • 2.2.3. Application
    • 2.2.4. End Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Computational Pathology Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
      • 3.1.1.1. Increasing prevalence of chronic diseases
      • 3.1.1.2. Higher cost-efficiency
      • 3.1.1.3. Rapid technological advancements in computational pathology
      • 3.1.1.4. Emergence of Quantitative Continuous Scoring (QCS) in digital pathology
    • 3.1.2. Market restraint analysis
      • 3.1.2.1. High cost of implementing digital and computational pathology solutions
      • 3.1.2.2. Stringent regulatory requirements
    • 3.1.3. Market Opportunity Analysis
    • 3.1.4. Market Challenge Analysis
  • 3.2. Case Study Insights
  • 3.3. Computational Pathology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. Technology Trends Analysis

Chapter 4. Computational Pathology Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Computational Pathology Market by Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Computational Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Computational Pathology Market by Application Outlook
  • 5.4. Disease Diagnosis
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Drug Discovery & Development
    • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Academic Research
    • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Computational Pathology Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Computational Pathology Market by Technology Outlook
  • 6.4. Machine Learning (ML)
    • 6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Deep Learning
      • 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Supervised
      • 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Unsupervised
      • 6.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Natural Language Processing (NLP) Models
    • 6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Computer Vision
    • 6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Computational Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2025 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Global Computational Pathology Market by End Use Outlook
  • 7.4. Hospitals and Diagnostic Labs
    • 7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Biotechnology and Pharmaceutical Companies
    • 7.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic and Research Institutes
    • 7.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Computational Pathology Market: Regional Estimates & Trend Analysis, By Component, By Application, By Technology, By End Use

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Singapore market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share/position analysis, 2025
  • 9.4. Company Profiles
    • 9.4.1. Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Hamamatsu Photonics K.K.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Koninklijke Philips N.V.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Olympus Corporation
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. F. Hoffmann-La Roche Ltd.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Aiforia/ Aiforia Technologies PLC
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Epredia (3DHISTECH Ltd.)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Visiopharm A/S
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Proscia Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Mindpeak GmbH
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Akoya Biosciences, Inc. (a Quanterix company)
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Paige AI, Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. CellaVision
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. aetherAI
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Qritive
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives
    • 9.4.16. IBEX (IBEX MEDICAL ANALYTICS)
      • 9.4.16.1. Company overview
      • 9.4.16.2. Financial performance
      • 9.4.16.3. Product benchmarking
      • 9.4.16.4. Strategic initiatives
    • 9.4.17. Nucleai, Inc.
      • 9.4.17.1. Company overview
      • 9.4.17.2. Financial performance
      • 9.4.17.3. Product benchmarking
      • 9.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Computational Pathology Market, by Region, 2021 - 2033 (USD Million)
  • Table 3 North America Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 4 North America Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 5 North America Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 6 North America Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 8 U.S. Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 9 U.S. Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 10 U.S. Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 11 Canada Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 12 Canada Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 13 Canada Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 15 Mexico Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 16 Mexico Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 17 Mexico Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Computational Pathology Market, by Region, 2021 - 2033 (USD Million)
  • Table 20 Europe Computational Pathology Market, by Component, 2021 - 2033 (USD Million)
  • Table 21 Europe Computational Pathology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Europe Computational Pathology Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Europe Computational Pathology Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24 Germany Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 25 Germany Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 26 Germany Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 27 Germany Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 28 UK Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 29 UK Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 30 UK Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 31 UK Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 32 France Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 33 France Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 34 France Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 35 France Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 36 Italy Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 37 Italy Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 38 Italy Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 39 Italy Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 40 Spain Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 41 Spain Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 42 Spain Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 43 Spain Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 44 Denmark Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 45 Denmark Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 46 Denmark Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 47 Denmark Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 48 Sweden Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 49 Sweden Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 50 Sweden Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 51 Sweden Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 52 Norway Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 53 Norway Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 54 Norway Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 55 Norway Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific Computational Pathology Market, by region, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 61 China Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 62 China Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 63 China Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 64 China Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 65 Japan Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 66 Japan Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 67 Japan Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 68 Japan Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 69 India Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 70 India Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 71 India Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 72 India Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 73 South Korea Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 74 South Korea Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 75 South Korea Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 76 South Korea Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 77 Australia Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 78 Australia Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 79 Australia Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 80 Australia Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 81 Thailand Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 82 Thailand Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 83 Thailand Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 84 Thailand Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 85 Latin America Computational Pathology Market, by region, 2021 - 2033 (USD Million)
  • Table 86 Latin America Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 87 Latin America Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 88 Latin America Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 89 Latin America Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 90 Brazil Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 91 Brazil Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 92 Brazil Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 93 Brazil Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 94 Argentina Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 95 Argentina Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 96 Argentina Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 97 Argentina Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 98 MEA Computational Pathology Market, by region, 2021 - 2033 (USD Million)
  • Table 99 MEA Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 100 MEA Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 101 MEA Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 102 MEA Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 103 South Africa Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 104 South Africa Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 105 South Africa Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 106 South Africa Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 111 UAE Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 112 UAE Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 113 UAE Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 114 UAE Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 115 Kuwait Computational Pathology Market, 2021 - 2033 (USD Million)
  • Table 116 Kuwait Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 119 Kuwait Computational Pathology Market by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Computational Pathology Market outlook
  • Fig. 9 Computational Pathology competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Computational Pathology Market driver impact
  • Fig. 15 Computational Pathology Market restraint impact
  • Fig. 16 Computational Pathology Market strategic initiatives analysis
  • Fig. 17 Computational Pathology Market: Component movement analysis
  • Fig. 18 Computational Pathology Market: Component outlook and key takeaways
  • Fig. 19 Software market estimates and forecast, 2021 - 2033
  • Fig. 20 Services market estimates and forecast, 2021 - 2033
  • Fig. 21 Computational Pathology Market: Application movement analysis
  • Fig. 22 Computational Pathology Market: Application outlook and key takeaways
  • Fig. 23 Disease diagnosis market estimates and forecast, 2021 - 2033
  • Fig. 24 Drug discovery & development market estimates and forecast, 2021 - 2033
  • Fig. 25 Academic research market estimates and forecast, 2021 - 2033
  • Fig. 26 Computational Pathology Market: Technology movement analysis
  • Fig. 27 Computational Pathology Market: Technology outlook and key takeaways
  • Fig. 28 Machine Learning (ML) market estimates and forecast, 2021 - 2033
  • Fig. 29 Deep Learning market estimates and forecast, 2021 - 2033
  • Fig. 30 Supervised market estimates and forecast, 2021 - 2033
  • Fig. 31 Unsupervised market estimates and forecast, 2021 - 2033
  • Fig. 32 Others market estimates and forecast, 2021 - 2033
  • Fig. 33 Natural Language Processing (NLP) models market estimates and forecast, 2021 - 2033
  • Fig. 34 Computer vision market estimates and forecast, 2021 - 2033
  • Fig. 35 Others market estimates and forecast, 2021 - 2033
  • Fig. 36 Computational Pathology Market: End use movement analysis
  • Fig. 37 Computational Pathology Market: End use outlook and key takeaways
  • Fig. 38 Hospitals and Diagnostic Labs market estimates and forecast, 2021 - 2033
  • Fig. 39 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2021 - 2033
  • Fig. 40 Academic and Research Institutes market estimates and forecast, 2021 - 2033
  • Fig. 41 Other market estimates and forecast, 2021 - 2033
  • Fig. 42 Global Computational Pathology Market: Regional movement analysis
  • Fig. 43 Global Computational Pathology Market: Regional outlook and key takeaways
  • Fig. 44 Global Computational Pathology Market share and leading players
  • Fig. 45 North America market share and leading players
  • Fig. 46 Europe market share and leading players
  • Fig. 47 Asia Pacific market share and leading players
  • Fig. 48 Latin America market share and leading players
  • Fig. 49 Middle East & Africa market share and leading players
  • Fig. 50 North America market estimates and forecasts, 2021 - 2033
  • Fig. 51 US market estimates and forecasts, 2021 - 2033
  • Fig. 52 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 53 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 54 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 55 UK market estimates and forecasts, 2021 - 2033
  • Fig. 56 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 57 France market estimates and forecasts, 2021 - 2033
  • Fig. 58 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 59 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 60 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 61 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 62 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 63 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 64 China market estimates and forecasts, 2021 - 2033
  • Fig. 65 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 66 India market estimates and forecasts, 2021 - 2033
  • Fig. 67 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 68 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 69 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 70 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 71 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 72 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 74 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 76 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 77 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 78 Market share of key market players- Computational Pathology Market
  • Fig. 79 Key Company Categorization
  • Fig. 80 Company Market Share/Position Analysis, 2025
  • Fig. 81 Strategic Framework